Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The protocol allows the generation of a pure adipocyte population from induced pluripotent stem cells (iPSCs). Retinoic acid is used to differentiate iPSCs into mesenchymal stem cells (MSCs) which are used for producing adipocytes. Then, a sorting approach based on Nile red staining is used to obtain pure adipocytes.

Abstract

Recent advances in induced pluripotent stem cell (iPSC) technology have allowed the generation of different cell types, including adipocytes. However, the current differentiation methods have low efficiency and do not produce a homogenous population of adipocytes. Here, we circumvent this problem by using an all-trans retinoic-based method to produce mesenchymal stem cells (MSCs) in high yield. By regulating pathways governing cell proliferation, survival, and adhesion, our differentiation strategy allows the efficient generation of embryonic bodies (EBs) that differentiate into a pure population of multipotent MSCs. The high number of MSCs generated by this method provides an ideal source for generating adipocytes. However, sample heterogeneity resulting from adipocyte differentiation remains a challenge. Therefore, we used a Nile red-based method for purifying lipid-bearing mature adipocytes using FACS. This sorting strategy allowed us to establish a reliable way to model adipocyte-associated metabolic disorders using a pool of adipocytes with reduced sample heterogeneity and enhanced cell functionality.

Introduction

Mesenchymal stem cells (MSCs) act as an effective transitory resource for producing cells of mesodermal origin like adipocytes, osteocytes, and chondrocytes, which could be further used for modeling their respective genetic disorders. However, previous approaches relied on attaining these MSCs from adult tissues1, which imposed the challenge of obtaining them in high numbers from the donors, and the limitation of keeping them functionally viable in suboptimal in vitro culture conditions1,2. These obstacles have produced a great demand of having a protocol for generating MSCs

Protocol

The study has been approved by the appropriate institutional research ethics committee and performed following the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The protocol was approved by the Institutional Review Board (IRB) of HMC (no. 16260/16) and QBRI (no. 2016-003). This work is also optimized for hESCs such as H1 and H9. Blood samples were obtained from healthy individuals with full informed consent. The iPSCs are generated from periph.......

Representative Results

Schematic and morphology of cells during mesenchymal differentiation: Differentiation of iPSCs into MSCs involves various stages of development spanning across EB formation, MSC differentiation, and MSC expansion (Figure 1). During these stages of development, cells acquire various morphology owing to the different stimulatory chemicals they are subjected to. Upon initiating differentiation, cells are plated in suspension and are expected to be round, with defined cell borders, while being s.......

Discussion

This protocol holds paramount importance due to its ability to provide MSCs in high yield and efficiency. This mass-scale production of MSCs was made possible by transient incubation of iPSCs-derived EBs with 10 µM of RA14,15. Transient treatment with 10 µM of RA enhanced the MSC yield by 11.2 to 1542 folds14,15, with this protocol being applicable on both iPSCs and hPSCs. At this dose and durat.......

Acknowledgements

This work was funded by a grant from Qatar National Research Fund (QNRF) (Grant No. NPRP10-1221-160041). Maryam Aghadi was supported by GSRA scholarship from Qatar National Research Fund (QNRF).

....

Materials

NameCompanyCatalog NumberComments
AdiponectinAbcamab22554Adipocyte maturation marker
anti-CD105BD Pharmingen560839MSC differentiation marker
anti-CD14BD Pharmingen561712MSC differentiation marker
anti-CD19BD Pharmingen555415MSC differentiation marker
anti-CD34BD Pharmingen555824MSC differentiation marker
anti-CD44abcamab93758MSC differentiation marker
anti-CD45BD Pharmingen
560975
MSC differentiation marker
anti-CD73BD Pharmingen550256MSC differentiation marker
anti-CD90BD Pharmingen555596MSC differentiation marker
bFGFR&D233-FPMSC culture media supplement
C/EBPAAbcamab40761Adipocyte maturation marker
DexamethasoneTorics1126Adipocyte differentiation media supplement
FABP4Abcamab93945Adipocyte maturation marker
Fetal bovine serumThermoFisher10082147MSC culture media supplement
GlutamaxThermoFisher35050-061MSC culture media supplement
IBMXSigma AldrichI5879Adipocyte differentiation media supplement
IndomethacinSigma AldrichI7378Adipocyte differentiation media supplement
InsulinSigma Aldrich91077CAdipocyte differentiation media supplement
Knockout DMEMThermoFisher12660012Basal media for preparing matrigel
Low glucose DMEMThermoFisher11885084MSC culturing media
MatrigelCorning354230Coating matrix
MEM-alphaThermoFisher12561056Adipocyte differentiation media
NileredSigma Aldrich19123Sorting marker for adipocyte
PenicillinThermoFisher15140122MSC/Adipocyte media supplement
Phosphate-buffered salineThermoFisher14190144wash buffer
Pierceâ„¢ 20X TBS BufferThermo Fisher28358wash buffer
PPARGCell Signaling Technology2443Adipocyte maturation marker
ReLeSRStem Cell Technologies5872Dissociation reagent
Retinoic acidSigma AldrichR2625MSC differentiation media supplement
Rock inhibitorTocris1254/10hPSC culture media supplement
RoziglitazoneSigma AldrichR2408Adipocyte differentiation media supplement
StemFlexThermoFisherA334901hPSC culture media
TritonThermo Fisher28314Permebealization reagent
TrypsinThermoFisher25200072Dissociation reagent
Tween 20Sigma AldrichP7942Wash buffer

References

  1. Hass, R., Kasper, C., Bohm, S., Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling: CCS. 9, 12 (2011).
  2. Wagner, W., et al.

Explore More Articles

Human IPSCsAdipocyte DifferentiationMesenchymal Stem CellsNile Red SortingMSC Differentiation MediaRetinoic AcidEmbryonic BodiesDMEM Low glucose Medium

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved